|
Name |
Benzo(qr)naphtho(2,1,8,7-fghi)pentacene
|
Molecular Formula | C30H16 | |
IUPAC Name* |
octacyclo[16.12.0.02,15.03,12.04,29.06,11.019,24.025,30]triaconta-1(18),2(15),3(12),4,6,8,10,13,16,19,21,23,25(30),26,28-pentadecaene
|
|
SMILES |
C1=CC=C2C3=C4C(=CC2=C1)C5=CC=CC6=C5C7=C(C=CC(=C47)C=C3)C8=CC=CC=C68
|
|
InChI |
InChI=1S/C30H16/c1-2-7-19-18(6-1)16-26-23-11-5-10-22-20-8-3-4-9-21(20)25-15-13-17-12-14-24(19)29(26)27(17)30(25)28(22)23/h1-16H
|
|
InChIKey |
AVVLVJLIKRMPQZ-UHFFFAOYSA-N
|
|
Synonyms |
Benzo(qr)naphtho(2,1,8,7-fghi)pentacene; Benzo[qr]naphtho[2,1,8,7-fghi]pentacene; 190-87-4; tribenzo[b,k,pqr]perylene; DTXSID30172461
|
|
CAS | 190-87-4 | |
PubChem CID | 136010 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 376.4 | ALogp: | 8.9 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 8 |
Heavy Atoms: | 30 | QED Weighted: | 0.167 |
Caco-2 Permeability: | -5.177 | MDCK Permeability: | 0.00001220 |
Pgp-inhibitor: | 0.211 | Pgp-substrate: | 0.952 |
Human Intestinal Absorption (HIA): | 0.932 | 20% Bioavailability (F20%): | 0.997 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.086 | Plasma Protein Binding (PPB): | 88.98% |
Volume Distribution (VD): | 1.259 | Fu: | 0.28% |
CYP1A2-inhibitor: | 0.972 | CYP1A2-substrate: | 0.151 |
CYP2C19-inhibitor: | 0.544 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.287 | CYP2C9-substrate: | 0.944 |
CYP2D6-inhibitor: | 0.199 | CYP2D6-substrate: | 0.946 |
CYP3A4-inhibitor: | 0.119 | CYP3A4-substrate: | 0.034 |
Clearance (CL): | 3.606 | Half-life (T1/2): | 0.024 |
hERG Blockers: | 0.053 | Human Hepatotoxicity (H-HT): | 0.06 |
Drug-inuced Liver Injury (DILI): | 0.987 | AMES Toxicity: | 0.775 |
Rat Oral Acute Toxicity: | 0.126 | Maximum Recommended Daily Dose: | 0.924 |
Skin Sensitization: | 0.985 | Carcinogencity: | 0.952 |
Eye Corrosion: | 0.011 | Eye Irritation: | 0.995 |
Respiratory Toxicity: | 0.816 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001018 | 0.417 | D08PCE | 0.315 | ||||
ENC005492 | 0.393 | D00HPK | 0.303 | ||||
ENC000338 | 0.318 | D02JYY | 0.299 | ||||
ENC002351 | 0.312 | D0H5LK | 0.298 | ||||
ENC002352 | 0.312 | D01VMO | 0.297 | ||||
ENC000894 | 0.306 | D0AA2D | 0.296 | ||||
ENC001752 | 0.295 | D0VU2X | 0.288 | ||||
ENC001521 | 0.295 | D0G9YH | 0.288 | ||||
ENC001962 | 0.291 | D04VKS | 0.281 | ||||
ENC003535 | 0.291 | D0U3ED | 0.280 |